SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-beta/Smad pathway. Qi C, Lyu M, Yao Z, Zhang F, et al. Gynecol Oncol 2024;190:167-178.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qi C, Lyu M, Yao Z, Zhang F, et al. SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-beta/Smad pathway. Gynecol Oncol 2024;190:167-178.
PMID: 39197416